Your browser doesn't support javascript.
loading
The NCI-MATCH trial: lessons for precision oncology.
O'Dwyer, Peter J; Gray, Robert J; Flaherty, Keith T; Chen, Alice P; Li, Shuli; Wang, Victoria; McShane, Lisa M; Patton, David R; Tricoli, James V; Williams, P Mickey; Iafrate, A John; Sklar, Jeffrey; Mitchell, Edith P; Takebe, Naoko; Sims, David J; Coffey, Brent; Fu, Tony; Routbort, Mark; Rubinstein, Larry V; Little, Richard F; Arteaga, Carlos L; Marinucci, Donna; Hamilton, Stanley R; Conley, Barbara A; Harris, Lyndsay N; Doroshow, James H.
Afiliación
  • O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA, USA. peter.odwyer@pennmedicine.upenn.edu.
  • Gray RJ; Dana-Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA.
  • Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Li S; Dana-Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA.
  • Wang V; Dana-Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA.
  • McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD, USA.
  • Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Iafrate AJ; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Sklar J; Yale University, New Haven, CT, USA.
  • Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA, USA.
  • Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Sims DJ; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Coffey B; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD, USA.
  • Fu T; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Routbort M; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX, USA.
  • Marinucci D; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA.
  • Hamilton SR; City of Hope National Medical Center, Duarte, CA, USA.
  • Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
  • Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Nat Med ; 29(6): 1349-1357, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37322121
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos